drug discovery

Structural characteristics and evolutionary trajectories of knowledge recombination in the field of AI-driven drug discovery

by

The Evolution of AI in Drug Discovery: From Lab to Algorithm The landscape of pharmaceutical research is undergoing a fundamental shift. What once relied heavily on traditional pharmaceutical methods (A61K) has evolved into a sophisticated integration of computing (G06F) and, more recently, bioinformatics (G16B). View this post on Instagram about Drug, Bioinformatics From Instagram — … Read more

Curcumin and ferulic acid activate PPARγ–PGC1α signaling and improve mitochondrial function in a 6-OHDA-induced Parkinson’s cellular model

by

Beyond Symptom Management: The Rise of Neuroprotective Strategies in Parkinson’s For years, the primary approach to managing Parkinson’s disease (PD) has focused on replacing depleted dopamine in the striatum using levodopa or dopamine receptor agonists. Although these treatments address the immediate symptoms, they often lead to variable therapeutic effects and the development of undesirable dyskinesia … Read more

The age of animal experiments is waning. Where will science go next?

by

The End of Animal Testing? A Global Shift Towards Humane Science For decades, the use of animals in scientific research has been a subject of ethical debate. Now, a confluence of factors – growing ethical concerns, advancements in technology, and regulatory changes – is driving a global movement to phase out animal testing. From the … Read more

Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs

by

Recent Alliance Targets Malaria’s Achilles’ Heel: The Parasite’s Skeleton A groundbreaking research collaboration between the Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc. Promises a fresh approach to combating malaria. Supported by the Gates Foundation, the partnership focuses on disrupting the Plasmodium parasite’s cytoskeleton – a strategy that could unlock a new … Read more

Bioactivity screening of endophytic fungi from Sterculia urens and GC–MS metabolites profiling of the potent isolate Chaetomium meridiolense

by

Why Endophytic Chaetomium Is the Next Substantial Thing in Natural Product Discovery Researchers are increasingly turning to endophytic fungi as a treasure chest of bioactive chemicals. Among them, the genus Chaetomium stands out for its diverse secondary metabolites – from indole alkaloids to chaetoglobosins – that demonstrate promise in medicine, agriculture and industry. Key Discoveries … Read more

Thermodynamic insights into histamine H1 receptor ligand binding

by

The Future of Drug Design: Beyond Binding Affinity to Enthalpy and Entropy For decades, drug discovery has largely focused on how tightly a molecule binds to its target. But a paradigm shift is underway, driven by a deeper understanding of the thermodynamic forces at play. Recent research, spearheaded by Professor Mitsunori Shiroishi at Tokyo University … Read more

Lanthanide–carbamazepine complexes: synthesis, spectroscopic characterization, DFT Insights, molecular docking, and biological evaluation

by

From Wastewater to Medicine: How Carbamazepine Research is Shaping Future Technologies Carbamazepine (CBZ) is a widely used antiepileptic drug that stubbornly persists in water bodies. Recent studies reveal a surge of innovative approaches—from advanced oxidation to smart inclusion complexes—that not only promise cleaner water but also open doors to fresh therapeutic agents. Advanced Oxidation: The … Read more

TLC-2716/6665: Preclinical & Phase 1 Data on a Novel LXR Agonist for Dyslipidemia & NASH

by

The Future of Metabolic Disease Treatment: Beyond Statins and Towards Precision Therapies The fight against metabolic diseases like type 2 diabetes, non-alcoholic steatohepatitis (NASH), and hyperlipidemia is entering a new era. Recent research, detailed in studies examining compounds like TLC-2716 and TLC-6665, points towards a future where treatments aren’t one-size-fits-all, but tailored to individual genetic … Read more

MK-7762: Antibacterial Activity, PK, and Efficacy in Tuberculosis Models

by

The Future of Tuberculosis Treatment: Beyond the Bench and Into the Body Tuberculosis (TB), a disease once thought to be fading into history, is staging a concerning comeback. Drug resistance is escalating, and existing treatments are lengthy and often debilitating. However, a wave of cutting-edge research, detailed in recent studies like the one exploring MK-7762, … Read more

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

by

Novartis’ Florida Expansion Signals a New Era for Targeted Cancer Therapies Novartis’ announcement of a new $23 billion investment in US manufacturing, culminating in a fourth radioligand therapy (RLT) facility in Winter Park, Florida, isn’t just about bricks and mortar. It’s a strategic move signaling a fundamental shift in how we approach cancer treatment – … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]